Journal Review 2025: Practical Overview of I-123 Ioflupane Imaging in Parkinsonian Syndromes

Course overview

UAN: 0018-0000-25-065-H01-P RELEASE: 12/05/2025 EXPIRE: 12/05/2026 CREDITS: 1.5 LEARNING OBJECTIVES: 1.Review the anatomy, pathophysiology and epidemiology of Parkinsonian syndromes 2.Understand the clinical presentation, diagnosis and management of Parkinson syndromes 3.Recognize the radiopharmaceutical properties and adverse reactions associated with the use of I-123 ioflupane 4.Understand the interpretation criteria for dopamine transporter imaging 5. Identify alternatives to ioflupane imaging NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the Radiopharmacy Portal a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $225 for nuclear pharmacists and $125 for nuclear pharmacy technicians.